SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
即时热点
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
活力老虎
Lv0
1
0 积分
2024-04-14 加入
最近求助
最近应助
互助留言
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
2小时前
已完结
Anlotinib enhanced penpulimab efficacy through remodeling of tumor vascular architecture and immune microenvironment in hPD-L1/hPD-1 humanized mouse model
2小时前
已完结
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
3个月前
已完结
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
3个月前
已完结
PD-L1 Expression in Endocervical Adenocarcinoma
3个月前
已完结
Programmed death‐ligand 1 expression in human papillomavirus‐independent cervical adenocarcinoma and its prognostic significance
3个月前
已完结
Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance
3个月前
已完结
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
3个月前
已完结
Recent Developments in Non–HPV-related Adenocarcinomas of the Lower Female Genital Tract and Their Precursors
3个月前
已完结
Combined expression of the BRAFV600E mutation and PD-L1 in early papillary thyroid carcinoma and its relationship with clinicopathological features and recurrence—a retrospective cohort study
3个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论